LT2349204T - Inhaliacinės dalelės, apimančios tiotropiumą - Google Patents

Inhaliacinės dalelės, apimančios tiotropiumą

Info

Publication number
LT2349204T
LT2349204T LTEP09783687.8T LT09783687T LT2349204T LT 2349204 T LT2349204 T LT 2349204T LT 09783687 T LT09783687 T LT 09783687T LT 2349204 T LT2349204 T LT 2349204T
Authority
LT
Lithuania
Prior art keywords
tiotropium
inhalable particles
inhalable
particles
Prior art date
Application number
LTEP09783687.8T
Other languages
English (en)
Inventor
Karim Amighi
Antonio Sereno Guerra
Original Assignee
Laboratorios Liconsa, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2349204(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liconsa, S.A. filed Critical Laboratorios Liconsa, S.A.
Publication of LT2349204T publication Critical patent/LT2349204T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Electrolytic Production Of Metals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTEP09783687.8T 2008-10-02 2009-10-02 Inhaliacinės dalelės, apimančios tiotropiumą LT2349204T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08382040A EP2172190A1 (en) 2008-10-02 2008-10-02 Inhalable particles comprising tiotropium
US10411308P 2008-10-09 2008-10-09
PCT/EP2009/062821 WO2010037845A1 (en) 2008-10-02 2009-10-02 Inhalable particles comprising tiotropium

Publications (1)

Publication Number Publication Date
LT2349204T true LT2349204T (lt) 2018-10-10

Family

ID=40348057

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP09783687.8T LT2349204T (lt) 2008-10-02 2009-10-02 Inhaliacinės dalelės, apimančios tiotropiumą

Country Status (39)

Country Link
US (1) US20110311618A1 (lt)
EP (2) EP2172190A1 (lt)
JP (1) JP5622730B2 (lt)
KR (1) KR101639089B1 (lt)
CN (1) CN102170861B (lt)
AR (1) AR073528A1 (lt)
AU (1) AU2009299801B2 (lt)
BR (1) BRPI0920706B8 (lt)
CA (1) CA2737399C (lt)
CL (1) CL2011000696A1 (lt)
CO (1) CO6361899A2 (lt)
CR (1) CR20110227A (lt)
CY (1) CY1121090T1 (lt)
DK (1) DK2349204T3 (lt)
DO (1) DOP2011000091A (lt)
EC (1) ECSP11010925A (lt)
ES (1) ES2675857T3 (lt)
HN (1) HN2011000864A (lt)
HR (1) HRP20181009T1 (lt)
HU (1) HUE038208T2 (lt)
LT (1) LT2349204T (lt)
MA (1) MA34560B1 (lt)
MX (1) MX2011003491A (lt)
MY (1) MY159172A (lt)
NI (1) NI201100066A (lt)
NZ (1) NZ591923A (lt)
PE (2) PE20110850A1 (lt)
PL (1) PL2349204T3 (lt)
PT (1) PT2349204T (lt)
RU (2) RU2685236C2 (lt)
SI (1) SI2349204T1 (lt)
SM (1) SMT201800350T1 (lt)
SV (1) SV2011003852A (lt)
TR (1) TR201808269T4 (lt)
TW (1) TWI433675B (lt)
UA (1) UA100777C2 (lt)
UY (1) UY32160A (lt)
WO (1) WO2010037845A1 (lt)
ZA (1) ZA201101735B (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012138909A (ru) * 2010-03-31 2014-05-10 Гленмарк Фармасьютикалс Лимитед Фармацевтическая порошковая композиция для ингаляций
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
WO2011154014A1 (en) * 2010-06-11 2011-12-15 Gea Process Engineering A/S Controlled humidity drying
US9693955B2 (en) 2010-08-23 2017-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Humidified particles comprising a therapeutically active substance
WO2013109213A2 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Pharmaceutical formulations comprising tiotropium
DE102013012914A1 (de) 2012-08-03 2014-02-20 Gheorghe George Olaru Hot runner injection molding apparatus with additional controller
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
EP3515439B1 (en) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising tiotropium bromide
EP4108230A1 (en) * 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation
GR1010358B (el) * 2021-09-14 2022-12-16 Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο
CN114191418B (zh) * 2021-12-21 2023-06-09 丽珠医药集团股份有限公司 噻托溴铵双层微球及其制备方法和噻托溴铵缓释吸入剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
US20020081266A1 (en) * 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
PL200063B1 (pl) 2000-10-12 2008-12-31 Boehringer Ingelheim Pharma Nowe proszki do inhalacji zawierające tiotropium
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
US6485279B2 (en) * 2000-12-26 2002-11-26 Carrier Corporation Thrust load reliever
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
ES2718455T3 (es) * 2002-03-20 2019-07-02 Civitas Therapeutics Inc Formulaciones terapéuticas sostenidas inhalables
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
DE10339197A1 (de) * 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
KR101395881B1 (ko) * 2005-12-19 2014-05-21 시코르, 인크. 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법
AU2007208998A1 (en) * 2006-01-27 2007-08-02 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A method of producing porous microparticles
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations

Also Published As

Publication number Publication date
HUE038208T2 (hu) 2018-10-29
RU2685236C2 (ru) 2019-04-17
MX2011003491A (es) 2011-06-16
ECSP11010925A (es) 2011-07-29
UA100777C2 (ru) 2013-01-25
ZA201101735B (en) 2012-05-30
ES2675857T3 (es) 2018-07-13
BRPI0920706B8 (pt) 2021-05-25
TW201018468A (en) 2010-05-16
SI2349204T1 (en) 2018-08-31
CN102170861B (zh) 2014-05-14
MY159172A (en) 2016-12-30
DOP2011000091A (es) 2011-04-30
DK2349204T3 (en) 2018-07-16
CR20110227A (es) 2011-06-24
MA34560B1 (fr) 2013-10-02
JP5622730B2 (ja) 2014-11-12
PL2349204T3 (pl) 2018-09-28
KR20110081265A (ko) 2011-07-13
CL2011000696A1 (es) 2011-07-29
RU2011117256A (ru) 2012-11-10
EP2349204A1 (en) 2011-08-03
PT2349204T (pt) 2018-07-06
CY1121090T1 (el) 2019-12-11
RU2014150986A (ru) 2015-06-10
CA2737399A1 (en) 2010-04-08
EP2349204B1 (en) 2018-04-11
WO2010037845A1 (en) 2010-04-08
BRPI0920706B1 (pt) 2021-02-02
US20110311618A1 (en) 2011-12-22
EP2172190A1 (en) 2010-04-07
SV2011003852A (es) 2011-04-12
UY32160A (es) 2010-04-30
RU2014150986A3 (lt) 2018-07-02
AR073528A1 (es) 2010-11-10
AU2009299801A1 (en) 2010-04-08
CA2737399C (en) 2017-02-21
PE20110850A1 (es) 2011-11-25
NZ591923A (en) 2012-02-24
CO6361899A2 (es) 2012-01-20
BRPI0920706A2 (pt) 2015-12-29
TWI433675B (zh) 2014-04-11
JP2012504580A (ja) 2012-02-23
TR201808269T4 (tr) 2018-07-23
AU2009299801B2 (en) 2014-02-27
CN102170861A (zh) 2011-08-31
SMT201800350T1 (it) 2018-09-13
NI201100066A (es) 2012-01-05
HN2011000864A (es) 2015-02-09
HRP20181009T1 (hr) 2018-08-24
PE20142435A1 (es) 2015-01-11
KR101639089B1 (ko) 2016-07-12

Similar Documents

Publication Publication Date Title
ZA201101735B (en) Inhalable particles comprising tiotropium
GB0907372D0 (en) Particles
IL217968A (en) inhaler
PL2358223T3 (pl) Inhalator
GB0818476D0 (en) Inhaler
GB0901520D0 (en) Inhaler
ZA201108257B (en) Inhaler
AU331057S (en) Inhaler
PL2647399T5 (pl) Inhalator
PL2082769T3 (pl) Inhalator
IL209233A0 (en) Inhaler
GB0910537D0 (en) Inhaler
IL207159A0 (en) Inhaler
GB0809493D0 (en) Inhaler
IL207157A0 (en) Inhaler
GB0922519D0 (en) Inhaler
GB0922546D0 (en) Inhaler
GB0922545D0 (en) Inhaler
GB0910919D0 (en) Inhaler
GB0808243D0 (en) Inhaler
GB0807057D0 (en) Inhaler
PH32008001030S1 (en) Inhaler
TWM388902U (en) Dual-purpose pillow